Soleo Health

What Soleo Health does

Soleo Health is an independent national specialty pharmacy and home/alternate-site infusion therapy provider headquartered in Frisco, Texas. The company operates 28-29 specialty pharmacy locations and more than 30 ambulatory infusion centers with pharmacy licensure and national nursing coverage in all 50 states, dispensing specialty medications and administering infusion therapies for patients with complex, chronic, and rare conditions including autoimmune disease, immune deficiency, neurological disorders (multiple sclerosis, myasthenia gravis, Alzheimer's anti-amyloid therapy), bleeding disorders, and rare/ultra-rare/orphan diseases. Its clinical model is organized around Therapeutic Care Management Centers dedicated to specific disease states, staffed by interdisciplinary teams of therapy-care pharmacists, registered nurses, reimbursement specialists, and patient care ambassadors.

The technology platform consists of three core layers. Soleo Connect is a HIPAA-compliant patient and provider communication and care management platform delivered via web portal and mobile apps (iOS and Android), integrating with the company's pharmacy and nursing systems for real-time data exchange. SoleMetrics is a proprietary outcomes program that collects longitudinal real-world patient data across clinical and therapeutic metrics (adherence, side effects, ER visits, hospitalizations, patient-reported outcomes) and produces customized reporting for physicians, health systems, payors, and pharmaceutical manufacturers, while supporting a Health Economics and Outcomes Research (HEOR) function. SoleoRare, launched in April 2026, is a dedicated rare disease specialty pharmacy sub-brand covering 60+ rare disease therapies and supporting 5,000+ rare disease patients. The company holds URAC Specialty Pharmacy accreditation and ACHC accreditation with Distinction in Rare Diseases and Orphan Drugs.

Soleo Health generates revenue primarily through specialty pharmacy dispensing and home/ambulatory infusion services, reimbursed via medical and pharmacy benefits, patient copays, manufacturer relationships, and clinical service fees. The go-to-market is sales-led and enterprise field sales, with therapeutic-area-organized sales teams targeting healthcare providers, health systems, pharmaceutical manufacturers, payors, and referring physician offices across all 50 states. The company is privately held, backed by a joint investment from Court Square Capital Partners and WindRose Health Investors made in February 2025 to support national expansion.

Name

Soleo Health

Legal name

Soleo Health

Website

https://soleohealth.com

Company type

Private

Founded year

2015

Operating status

Operating

Headcount range

251–500 employees

Short description

Soleo Health is a national specialty pharmacy and home/ambulatory infusion therapy provider operating in all 50 states, dispensing specialty medications and administering infusion therapies for patients with complex, chronic, and rare diseases. It serves patients, providers, payors, health systems, and pharmaceutical manufacturers through 28-29 pharmacy locations, 30+ infusion centers, and the SoleMetrics outcomes and Soleo Connect platforms.

Ownership category

akta.pro rank

Product category

Specialty Pharmacy and Infusion Therapy Services

NAICS

Home Health Care Services (62161), Ambulatory Health Care Services (621)

SIC

Services-Home Health Care Services (8082), Services-Misc Health & Allied Services, Nec (8090), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Independent Primary Care Practices (HLAFAGAA)

Keywords

• Specialty pharmacy services
• Home infusion therapy
• Ambulatory infusion centers
• Rare disease pharmacy
• Clinical care coordination

Headquarters

HQ city

Sharon Hill

HQ country

United States

HQ region

North America

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Supply Chain

Revenue model

1. Specialty Pharmacy Dispensing: Soleo Health generates revenue by dispensing specialty medications for complex and chronic conditions including rare diseases, neurological disorders, immunological conditions, and bleeding disorders. The company dispenses from its 28+ pharmacy locations and delivers medications to patients at home or at ambulatory infusion centers. Revenue is derived from insurance reimbursement (medical and pharmacy benefits), patient copays, and manufacturer relationships. Services include benefits investigation, prior authorization support, and financial assistance navigation.
2. Home Infusion and Ambulatory Infusion Center Services: Soleo Health provides infusion therapy services administered in patients' homes and at ambulatory infusion suites and centers (30+ nationwide). Infusion services include immunoglobulin therapy (IVIG and SCIG), biologics, anti-infectives, and other specialty infusions. Revenue is generated through medical benefit reimbursement, facility fees, and nursing services billed through health insurance plans including Medicare, Medicaid, and commercial payors.
3. SoleoRare — Rare Disease Specialty Pharmacy: SoleoRare, the company's dedicated rare disease specialty pharmacy brand launched April 2026, focuses on rare, ultra-rare, and orphan disease patients. The service provides clinical coordination, benefits navigation, site-of-care logistics, and pharmacy dispensing for rare disease therapies. Revenue is generated through specialty pharmacy dispensing and clinical service fees, with pharmaceutical manufacturer partnerships supporting distribution and patient support services.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels6 records

Core offering

Soleo Health is a national specialty pharmacy and infusion therapy provider that dispenses complex specialty medications and administers infusion therapies (IVIG, SCIG, biologics, anti-infectives) to patients with chronic, rare, and ultra-rare diseases. Services are delivered in patients' homes, at more than 30 ambulatory infusion centers, or in physician offices across all 50 U.S. states, supported by Therapeutic Care Management Centers organized by therapeutic area and proprietary platforms (Soleo Connect, SoleMetrics) for care coordination and outcomes reporting.

Product overview

Soleo Health is a leading independent national provider of complex specialty pharmacy services and infusion therapy administered in the home or at alternate sites of care. The company's offering is organized around a core platform of coordinated services: Soleo Connect® serves as the patient and provider communication hub (web portal and mobile app), while SoleMetrics® provides proprietary outcomes measurement and real-world data analytics. The recently launched SoleoRare™ sub-brand (April 2026) focuses specifically on rare, ultra-rare, and orphan disease patients, complementing the company's broader Therapeutic Care Management Centers for conditions including thyroid eye disease, myasthenia gravis, and multiple sclerosis. Services are delivered through a network of 28-29 specialty pharmacies (with pharmacy licensure in all 50 states), more than 30 ambulatory infusion suites and centers, national nursing coverage for home infusion, and an interdisciplinary team of clinical pharmacists, registered nurses, reimbursement specialists and patient care ambassadors. The June 2026 acquisitions of Realo Specialty Care Pharmacy and BluHaven Management expanded the Mid-Atlantic footprint. The company holds URAC and ACHC accreditations with distinction in rare diseases and orphan drugs.

Differentiator

Problem solved

Functional benefit

Brands

• Soleo Connect: A secure, HIPAA-compliant patient and provider communication and care management platform accessible via web portal and mobile app.
• SoleoRare
• SoleMetrics

Products and services

• Soleo Connect® HIPAA-compliant patient and provider communication and care management platform accessible via online portal and mobile app. Enables patients and caregivers to contact their care team, complete forms, sign documents, and receive information; providers can access patient records, complete and sign documents, view test results, and facilitate communication.
• SoleMetrics® Outcomes Program Proprietary outcomes program that collects real-world patient data over time to generate intelligent insights across the treatment journey. Tracks clinical and therapeutic metrics including patient experience, response to therapy, adherence, side effects, drug utilization, ER visits, hospitalizations, and catheter infections; provides customized reporting for physicians, health systems, payors, and manufacturers and supports HEOR research.
• SoleoRare™ Rare Disease Specialty Pharmacy Dedicated rare disease specialty pharmacy brand focused on rare, ultra-rare, and orphan disease patients. Provides therapy adoption support, access and affordability services, site-of-care administration, dispensing and fulfillment, and patient journey data insights; supports over 5,000 rare disease patients with 12+ years of rare disease experience.
• Home Infusion Therapy Home infusion therapy service delivering IV therapy or injectable medications to patients in their homes, with specialty pharmacy fulfillment and registered nurse administration; supports long-term treatment needs, mobility challenges, and transportation barriers for patients with chronic and complex conditions.
• Ambulatory Infusion Centers Network of more than 30 ambulatory infusion suites and centers nationwide offering outpatient infusion therapy with private or semi-private treatment suites, reclining chairs, complimentary amenities, free parking, and flexible scheduling; staffed by trained nurses and medical staff who administer treatments and monitor patients.
• Therapeutic Care Management Centers (TCMCs) Specialized care teams organized by therapeutic area, staffed with specially trained interdisciplinary teams including therapy-care pharmacists, registered nurses, reimbursement specialists, and patient-care ambassadors. Coordinate benefits verification, prior authorization, clinical monitoring, and ongoing patient support for complex therapies.
• Specialty Medication Dispensing Specialty medication dispensing for complex and chronic conditions across allergy and asthma, anti-infective therapies, bleeding disorders, cardiovascular, chronic inflammatory disorders, immunoglobulin therapies, neurological disorders, ophthalmologic conditions, and rare diseases; supported by insurance verification, prior authorization, and financial assistance navigation.
• Realo Specialty Care Pharmacy Specialty pharmacy acquired by Soleo Health in June 2026, located in Morrisville, N.C. Provides specialty pharmacy services combining clinical expertise with a patient-centered model for individuals and referring providers in the Mid-Atlantic region.
• BluHaven Management (BluHaven Health) Ambulatory infusion center acquired by Soleo Health in June 2026, located in Raleigh, N.C. Provides clinically supervised infusion services in a patient-focused care environment, complementing Soleo Health's regional specialty pharmacy operations.

Quantifiable outcome

• URAC Performance Measurement Pioneer — Second Consecutive Year (2025 Leaders in Performance Measurement Awards Program)
• +5 more outcomes

Segments5 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature3 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Realo Specialty Care PharmacycoreStrategic or Co-development Partner · 2 June 2026Soleo Health acquired Realo Specialty Care Pharmacy from Realo Drugs in June 2026. Founded in 2015, Realo Specialty Care is a leading specialty pharmacy in the Mid-Atlantic region (North Carolina, South Carolina, Virginia, and Maryland) with a best-in-class care model combining clinical expertise and care coordination. Principals Charlie Frye, PharmD, CSP, IgCP and Will Holland, PharmD, CSP, IgCP join Soleo Health.
• BluHaven Management (BluHaven Health)coreStrategic or Co-development Partner · 2 June 2026Soleo Health acquired BluHaven Management and its ambulatory infusion center BluHaven Health from Realo Drugs in June 2026. Located in Raleigh, N.C., BluHaven offers high-quality infusion therapy services in a patient-focused care environment, complementing Realo Specialty Care's regional pharmacy operations.
• American Academy of OphthalmologyminorOthersSoleo Health partners with the American Academy of Ophthalmology as an advocacy group for thyroid eye disease awareness and referral support.
• American Thyroid AssociationminorOthersSoleo Health partners with the American Thyroid Association for patient education and referral coordination for thyroid eye disease and other thyroid-related conditions.
• American Brain FoundationminorOthersSoleo Health partners with the American Brain Foundation for myasthenia gravis patient education and advocacy.
• Myasthenia Gravis Foundation of America (MGFA)minorOthersSoleo Health partners with the Myasthenia Gravis Foundation of America for MG patient advocacy, education, and referral support.
• National Multiple Sclerosis SocietyminorOthersSoleo Health partners with the National Multiple Sclerosis Society for MS patient resources, education, and referral coordination.

Scale indicators9 records

Recent moves8 records

Expansion highlights7 records

Direct peers

• Amerita: A specialty infusion company providing home and alternate-site infusion therapies across multiple U.S. markets. Overlaps with Soleo's home infusion and ambulatory infusion center services.
• Healix Infusion Therapy: A national provider of office-based and home infusion therapy services for patients with chronic conditions. Directly comparable to Soleo's AIC and home infusion offerings.
• ContinuumRx: A specialty pharmacy and home infusion provider focused on complex chronic therapies across the Mid-Atlantic and Southeast. Comparable to Soleo in its home/alternate-site infusion model and chronic-condition therapy mix.
• PANTHERx Rare Pharmacy: A leading U.S. rare and orphan disease specialty pharmacy offering dispensing, patient support, and HEOR data services. Its rare-disease focus and manufacturer partnership model closely parallel SoleoRare.
• BioPlus Specialty Pharmacy: A specialty pharmacy serving patients with complex conditions including oncology, autoimmune disease, and rare disorders. Now part of Elevance Health (CarelonRx), it directly competes with Soleo in specialty dispensing and manufacturer services.
• Optum Specialty Pharmacy: UnitedHealth Group/Optum's specialty pharmacy arm (built on the former Diplomat platform) dispenses specialty and rare disease therapies and provides home infusion. It is one of Soleo's most direct competitors given comparable therapeutic breadth and PBM ownership advantages.
• Accredo Health Group: Owned by Cigna/Evernorth, Accredo is the largest U.S. specialty pharmacy serving patients on complex therapies for chronic and rare diseases. It competes head-to-head with Soleo across specialty pharmacy dispensing, home infusion, and manufacturer services.

Regional players

• Vital Care Infusion Services: A franchised network of independent home and specialty infusion pharmacies across the U.S. It competes with Soleo in alternate-site infusion but primarily through independently owned regional locations rather than a single national brand.

Broad incumbents

• CVS Specialty: Aetna/CVS Health's specialty pharmacy services complex and chronic therapy patients. While part of a much broader retail/PBM franchise, its specialty capabilities and Caremark integration overlap directly with Soleo's offering.
• Walgreens Specialty Pharmacy: Walgreens' specialty and home infusion businesses (including the recent Blue Flame Health and Shields Health Solutions expansions) serve complex and chronic therapy patients nationwide, overlapping Soleo's site-of-care and specialty dispensing services.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xtwitter.com/soleohealth
• Facebookfacebook.com/soleohealth
• LinkedInlinkedin.com/company/soleohealth

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries2 records

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Soleo Health